154 related articles for article (PubMed ID: 31242987)
21. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma.
Baker DL; Schmidt ML; Cohn SL; Maris JM; London WB; Buxton A; Stram D; Castleberry RP; Shimada H; Sandler A; Shamberger RC; Look AT; Reynolds CP; Seeger RC; Matthay KK;
N Engl J Med; 2010 Sep; 363(14):1313-23. PubMed ID: 20879880
[TBL] [Abstract][Full Text] [Related]
22. Bilateral adrenal primary tumor in Stage 4S neuroblastoma: The Italian experience and review of the literature.
Montalto S; Sertorio F; Podda M; Sorrentino S; Di Cataldo A; Provenzi M; Nonnis A; D'Ippolito C; Corrias MV; De Bernardi B
Pediatr Hematol Oncol; 2022 Aug; 39(5):441-452. PubMed ID: 35139733
[TBL] [Abstract][Full Text] [Related]
23. Neuroblastoma in the newborn. A study of the Italian Neuroblastoma Registry.
Gigliotti AR; Di Cataldo A; Sorrentino S; Parodi S; Rizzo A; Buffa P; Granata C; Sementa AR; Fagnani AM; Provenzi M; Prete A; D'Ippolito C; Clerico A; Castellano A; Tonini GP; Conte M; Garaventa A; De Bernardi B
Eur J Cancer; 2009 Dec; 45(18):3220-7. PubMed ID: 19767197
[TBL] [Abstract][Full Text] [Related]
24. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
[TBL] [Abstract][Full Text] [Related]
25. Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7).
Mora J; Cruz O; Lavarino C; Rios J; Vancells M; Parareda A; Salvador H; Suñol M; Carrasco R; Guillen A; Mañé S; de Torres C
Clin Transl Oncol; 2015 Jul; 17(7):521-9. PubMed ID: 25596034
[TBL] [Abstract][Full Text] [Related]
26. Neonatal neuroblastoma 4s with diffuse liver metastases (Pepper syndrome) without an adrenal/extraadrenal primary identified on imaging.
Chaturvedi A; Katzman PJ; Franco A
J Radiol Case Rep; 2018 Mar; 12(3):18-27. PubMed ID: 29875990
[TBL] [Abstract][Full Text] [Related]
27. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
28. Neuroblastomas with discordant genotype-phenotype relationships: report of four cases with MYCN amplification and favorable histology.
Nakagawa A; Matsuoka K; Okita H; Iwafuchi H; Hori H; Kumagai M
Pediatr Dev Pathol; 2011; 14(2):87-92. PubMed ID: 21288077
[TBL] [Abstract][Full Text] [Related]
29. Management of stage 4S composite neuroblastoma with a MYCN-amplified nodule.
Bishop MW; Yin H; Shimada H; Towbin AJ; Miethke A; Weiss B
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e31-5. PubMed ID: 23528904
[TBL] [Abstract][Full Text] [Related]
30. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
31. Deferoxamine followed by cyclophosphamide, etoposide, carboplatin, thiotepa, induction regimen in advanced neuroblastoma: preliminary results. Italian Neuroblastoma Cooperative Group.
Donfrancesco A; De Bernardi B; Carli M; Mancini A; Nigro M; De Sio L; Casale F; Bagnulo S; Helson L; Deb G
Eur J Cancer; 1995; 31A(4):612-5. PubMed ID: 7576980
[TBL] [Abstract][Full Text] [Related]
32. Management and Outcomes of Children with Stage 4S (MS) Neuroblastoma: A Single-Center Experience from a Resource-Challenged Nation.
Anand S; Agarwala S; Jain V; Dhua A; Bakhshi S; Jana M; Kandasamy D; Biswas A
Indian J Pediatr; 2023 Mar; 90(3):220-226. PubMed ID: 36112265
[TBL] [Abstract][Full Text] [Related]
33. Stage IVS neuroblastoma: a clinical, histological, and biological analysis of 45 cases.
Hachitanda Y; Hata J
Hum Pathol; 1996 Nov; 27(11):1135-8. PubMed ID: 8912820
[TBL] [Abstract][Full Text] [Related]
34. Retrospective analysis of biological factors in a recurrent IV-S neuroblastoma with intermediate-grade malignancy.
Ikeda H; Nagashima K; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M; Hirato J
J Pediatr Surg; 1995 Jun; 30(6):866-9. PubMed ID: 7666325
[TBL] [Abstract][Full Text] [Related]
35. Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).
Rubie H; Michon J; Plantaz D; Peyroulet MC; Coze C; Frappaz D; Chastagner P; Baranzelli MC; Méchinaud F; Boutard P; Lutz P; Perel Y; Leverger G; de Lumley L; Millot F; Stéphan JL; Margueritte G; Hartmann O
Br J Cancer; 1998 Jun; 77(12):2310-7. PubMed ID: 9649151
[TBL] [Abstract][Full Text] [Related]
36. Stage IV neuroblastoma in infants. Long-term survival.
Paul SR; Tarbell NJ; Korf B; Kretschmar CS; Lavally B; Grier HE
Cancer; 1991 Mar; 67(6):1493-7. PubMed ID: 2001536
[TBL] [Abstract][Full Text] [Related]
37. Secondary leukemia in a child with neuroblastoma while on oral etoposide: what is the cause?
Ng A; Taylor GM; Eden OB
Pediatr Hematol Oncol; 2000; 17(3):273-9. PubMed ID: 10779995
[TBL] [Abstract][Full Text] [Related]
38. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
39. Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months.
Kawa K; Ohnuma N; Kaneko M; Yamamoto K; Etoh T; Mugishima H; Ohhira M; Yokoyama J; Bessho F; Honna T; Yoshizawa J; Nakada K; Iwafuchi M; Nozaki T; Mimaya J; Sawada T; Nakamura T; Miyata H; Yamato K; Tsuchida Y
J Clin Oncol; 1999 Oct; 17(10):3216-20. PubMed ID: 10506621
[TBL] [Abstract][Full Text] [Related]
40. High-dose carboplatin with etoposide (JET regimen) in children with advanced neuroblastoma.
Castello MA; Donfrancesco A; Clerico A; Cozza R; Dominici C; De Laurentis C; Properzi E; De Sio L; Schiavetti A; Deb G
Prog Clin Biol Res; 1991; 366():535-42. PubMed ID: 2068170
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
